Planned Asia-Pacific trial of NBTXR 3 intratumoral implant (activated by radiotherapy) for the treatment of cancer

Trial Profile

Planned Asia-Pacific trial of NBTXR 3 intratumoral implant (activated by radiotherapy) for the treatment of cancer

Planning
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2015

At a glance

  • Drugs NBTXR 3 (Primary)
  • Indications Head and neck cancer; Liver cancer; Oesophageal cancer; Oropharyngeal cancer; Rectal cancer; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jun 2015 Status changed from recruiting to planning.
    • 12 Jun 2015 Status changed from planning to recruiting.
    • 29 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top